Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg

• Conditions: Nfections, Enterobacterial

• Registration Number: NCT04995965
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Infections with enterobacteria producing carbapenemases at the University Hospitals of Strasbourg - descriptive epidemiology and risk factors for infection in the event of colonization

There is a worrying situation of an increase in the number of patients colonized with carbapenemase-producing Enterobacteriaceae (CPE) at HUS.

7 to 15% of patients colonized with EPC would develop an infection with EPC. The cohorts published mainly concern patients hospitalized in intensive care. The associated mortality reported in the literature is high (\> 25%) and greater than that associated with infection with the same bacterium sensitive to carbapenems.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-08
• Study Start: 2021-08-06
• Study First Submitted: 2021-08-06
• Study First Submitted QC: 2021-08-06
• Last Update Submitted: 2021-08-06
• Study First Posted: 2021-08-09
• Last Update Posted: 2021-08-09
• Primary Completion: 2022-01-06
• Study Completion: 2022-01-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 274

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Retrospective study of Enterobacteriaceae infections producing carbapenemases	Files analysed retrospectively from January 01, 2011 to July 31, 2021 will be examined]

Trial Locations

Locations (1)

Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg; 🇫🇷 Strasbourg, France